Top Science Longreads of 2013
By Ed Yong,
National Geographic
| 12. 23. 2013
I’m really optimistic about the future for long, deep, rich science reporting. There are more places that are publishing it, more ways of finding it, and a seemingly huge cadre of people who are writing it well. So without further ado, here’s a list of my top pieces of the year. It has blossomed to 15 from last year’s 12 because I was gripped by indecision and they’re all so good. In no particular order:
1)
Bones of Contention,
by Paige Williams for the New Yorker. The curious case of USA v. One Tyrannosaurus Bataar Skeleton frames this exquisitely crafted tale about a Florida man’s trade in Mongolian dinosaurs, and the amazing world of fossils, auctions, and private collectors.
“He sold sloth claws, elephant jaws, wolf molars, dinosaur ribs—a wide range of anatomical fragments that went, mostly, for between ten and fifty dollars. Increasingly, Florida Fossils got into triple digits, especially when Prokopi started selling dinosaur parts. In the fall of 2011, he sold two Mongolian oviraptor nests for more than three hundred and fifty dollars each, a...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...